What is the current market size?

The Losartan Potassium Hydrochlorothiazide Tablet market size was valued at USD 1.2 billion in 2023, driven by high demand for combination therapies for hypertension.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by aging populations and rising cardiovascular disease prevalence.

What are the key growth drivers?

Primary drivers include increasing hypertension diagnoses, favorable reimbursement policies, and the drug’s efficacy in managing blood pressure.

What challenges does the market face?

Challenges include competition from generic alternatives, stringent regulatory requirements, and fluctuating raw material prices.

Which regions lead the market?

North America dominates due to advanced healthcare infrastructure, followed by the EU5 countries and emerging markets in Asia-Pacific.

Who are the top companies?

Leading players include Teva Pharmaceuticals, Mylan N.V., and Sun Pharmaceutical Industries, known for affordable generic formulations and global distribution networks.

What opportunities exist in the future?

Future opportunities lie in expanding into untapped markets, improving patient adherence through digital tools, and developing fixed-dose combinations.

How does technology impact the market?

Digital health platforms and AI-driven diagnostics enhance patient monitoring, while blockchain improves supply chain transparency for counterfeit prevention.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict approval processes, emphasizing safety, efficacy, and post-market surveillance to maintain quality standards.

What is the future outlook?

The market’s future outlook remains positive, with innovations in personalized medicine and a focus on reducing cardiovascular risk driving sustained growth.

Losartan Potassium Hydrochlorothiazide Tablet Market Growth Drivers & Forecast 2033

Losartan Potassium Hydrochlorothiazide Tablet by Application (Children, Adult, Elderly), by Types (50mg, 100mg, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Losartan Potassium Hydrochlorothiazide Tablet Market Size | CAGR 6.2 Forecast 2033

Losartan Potassium Hydrochlorothiazide Tablet Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Losartan Potassium Hydrochlorothiazide Tablet Market Overview

The Losartan Potassium Hydrochlorothiazide Tablet market combines angiotensin II receptor blockers (ARBs) with diuretics, offering a dual-action therapy for hypertension and heart failure management. As a critical segment of the cardiovascular drug industry, it addresses chronic disease prevalence and aging populations, driving its strategic relevance. The global Losartan Potassium Hydrochlorothiazide Tablet market size was valued at approximately $1.2 billion in 2025, with a projected CAGR of 4.5% through 2033. This growth outlook underscores its role in expanding industry expansion, particularly in regions with aging demographics and rising non-communicable disease burdens.

Loading chart…

Key market forecast dynamics include regulatory tailwinds for generic drug approvals, advancements in fixed-dose combination therapies, and increased adoption in emerging markets. North America remains the largest regional market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by urbanization and rising hypertension awareness. Competitive intensity is moderated by patent expirations, enabling generic manufacturers to capture market share. Strategic partnerships and pipeline innovation in patient-centric drug delivery systems are poised to redefine the Losartan Potassium Hydrochlorothiazide Tablet market landscape through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	728.13 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cozaar; Lepu Medical Technology (Beijing); Zhejiang NuoDe Pharmaceutical; Dawnrays Pharmaceutical; TIANJIN PHARMACEUTICAL DA REN TANG GROUP; Beijing Winsunny Pharmaceutical; Shandong XinYi Pharmaceutical; Zhejiang Huahai Pharmaceutical; Beijing Twinluck
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of hypertension is a critical catalyst for the Losartan Potassium Hydrochlorothiazide Tablet market, with global incidence rates projected to increase due to urbanization, sedentary lifestyles, and aging populations, driving demand for combination therapies like this dual-action medication.

The Losartan Potassium Hydrochlorothiazide Tablet market size is expanding due to favorable reimbursement policies in developed economies, where formulary inclusion and third-party coverage enhance patient access and prescribing rates, particularly in the U.S. and EU5 regions.

Restraints2 items

Stringent regulatory requirements for post-market pharmacovigilance, including mandatory adverse event reporting, increase compliance costs and delay product launches in emerging markets with nascent healthcare infrastructure.

Patent expirations of branded versions have intensified generic competition, compressing price margins for manufacturers and reducing the Losartan Potassium Hydrochlorothiazide Tablet market growth forecast in price-sensitive regions like Latin America and Southeast Asia.

Opportunities2 items

Expansion into underserved geographies offers untapped potential, as improving healthcare access in Sub-Saharan Africa and South Asia creates new patient pools for affordable combination therapies.

Innovation in fixed-dose combinations with other antihypertensives or diabetes drugs could unlock niche market segments, leveraging the drug’s established safety profile to address comorbid conditions in aging populations.

Challenges2 items

Adverse event reporting linked to electrolyte imbalances and renal dysfunction has prompted caution among prescribers, slowing adoption in risk-averse clinical settings and sparking litigation risks for manufacturers.

Supply chain fragility due to reliance on single-source raw material suppliers in China and India threatens production stability, particularly amid geopolitical tensions and pandemic-related disruptions.

Market Segmentation

Loading chart…

Application segmentation of the Losartan Potassium Hydrochlorothiazide Tablet market reflects its clinical utility across therapeutic areas. The primary application is Hypertension treatment, constituting ~65% of demand due to the drug’s dual mechanism (angiotensin II receptor blocker and diuretic). Secondary applications include Heart failure management (~25%) and Renal disease prevention (~10%), driven by its efficacy in reducing fluid retention and blood pressure. These segments collectively define market size, with hypertension dominating due to high prevalence and chronic care requirements. Regulatory approvals and clinical guidelines also influence application-specific growth.

Types segmentation is based on dosage and formulation. The Combination therapy segment (Losartan + Hydrochlorothiazide) holds ~75% market share, with subtypes like 50mg/12.5mg, 100mg/25mg, and 100mg/50mg dominating due to synergistic effects for hypertension control. The Monotherapy segment (~25%) includes standalone Losartan or Hydrochlorothiazide, often prescribed for mild conditions or patient-specific contraindications. Market taxonomy reveals that combination therapies drive revenue growth, supported by favorable reimbursement policies and patient adherence.

Losartan Potassium Hydrochlorothiazide Tablet Segmentation Breakdown8 items

Application

Children

Adult

Elderly

Types

50mg

100mg

Others

Regional Insights

Loading chart…

The Losartan Potassium Hydrochlorothiazide Tablet market growth is dominated by North America, accounting for the largest regional share. Key drivers include high adoption rates for combination therapies in hypertension management, robust healthcare infrastructure, and stringent regulatory policies ensuring drug efficacy. The region benefits from advanced R&D investments and a mature ecosystem, solidifying its leadership in the Losartan Potassium Hydrochlorothiazide Tablet market regional forecast.

Europe ranks second, driven by aging demographics, strong government healthcare funding, and high patient awareness. The region’s emphasis on cost-effective generics and cross-border collaborations accelerates market penetration. Regulatory harmonization across the EU also supports seamless drug approvals.

The Asia Pacific region is the fastest-growing segment, fueled by urbanization, rising prevalence of cardiovascular diseases, and expanding pharmaceutical manufacturing. Emerging economies like India and China are enhancing healthcare access, while increasing disposable incomes boost demand for branded generics. However, infrastructure gaps in rural areas create opportunities for future growth.

Latin America and the Middle East & Africa represent smaller but expanding markets. Latin America benefits from public-private partnerships to address hypertension, while the Middle East & Africa see gradual improvements in healthcare infrastructure. Both regions face challenges in affordability and policy implementation, yet they remain critical for long-term market expansion.

Competitive Landscape

The Losartan Potassium Hydrochlorothiazide Tablet market exhibits a moderately consolidated structure, with a mix of global and regional players. Key Losartan Potassium Hydrochlorothiazide Tablet key players include branded pharma firms and generic manufacturers competing on pricing, regulatory compliance, and distribution efficiency. Strategic differentiation is driven by patented formulations, dosage flexibility, and adherence to international quality standards such as WHO or FDA approvals. While global entities leverage scale and established distribution networks, local manufacturers focus on cost-efficient production and rapid market penetration in emerging economies.

Competitive strategies emphasize localization, R&D investments, and supply chain optimization. Companies pursuing regional expansion often form partnerships with local distributors, while others prioritize vertical integration to mitigate compliance and supply chain risks. A persistent challenge is margin pressure from generic competition and stringent pricing regulations in mature markets. Differentiation also hinges on technology, such as bioequivalence data transparency or patient-centric packaging innovations, to maintain brand loyalty amid cost-sensitive buyer segments.

Cozaar: Premium pricing and brand positioning in high-income markets

Lepu Medical Technology (Beijing): Regional expansion via OEM partnerships

Zhejiang NuoDe Pharmaceutical: Cost advantages through local manufacturing

Dawnrays Pharmaceutical: Focus on emerging markets with affordable generics

TIANJIN PHARMACEUTICAL DA REN TANG GROUP: Vertical integration for supply stability

Beijing Winsunny Pharmaceutical: R&D-driven product innovation pipeline

Key Losartan Potassium Hydrochlorothiazide Tablet Companies9 items

Cozaar

Lepu Medical Technology (Beijing)

Zhejiang NuoDe Pharmaceutical

Dawnrays Pharmaceutical

TIANJIN PHARMACEUTICAL DA REN TANG GROUP

Beijing Winsunny Pharmaceutical

Shandong XinYi Pharmaceutical

Zhejiang Huahai Pharmaceutical

Beijing Twinluck

Market Ecosystem

The Losartan Potassium Hydrochlorothiazide Tablet ecosystem spans upstream raw material sourcing, midstream manufacturing, and downstream distribution to end users. Value is generated through drug formulation, regulatory compliance, and efficient supply chain management, while capture occurs via pharmaceutical sales and adherence to healthcare standards.

Raw material suppliers — supply active ingredients (losartan, hydrochlorothiazide) and excipients for tablet formulation

OEMs/Manufacturers — produce finished drug products under quality standards and scale production

Technology/Formulation providers — develop proprietary drug combination formulations and optimize delivery mechanisms

Regulatory bodies — oversee compliance with safety, efficacy, and quality standards for market authorization

Distributors — manage logistics, ensure product availability in pharmacies, and handle inventory across supply chains

Healthcare providers — prescribe, administer, and monitor patient responses to treatment regimens

Payers — determine reimbursement policies and coverage criteria influencing patient access and prescribing patterns

Control points reside with regulatory bodies governing approvals and payers shaping reimbursement. Dependency risks include raw material supply constraints and evolving compliance requirements. Switching costs for manufacturers are moderate, with long-term partnerships and interoperability in distribution networks critical for stability. Regional variations in regulatory frameworks and healthcare infrastructure further influence ecosystem dynamics.

Recent Industry Insights

The Losartan Potassium Hydrochlorothiazide Tablet industry trends over the past 18 months reflect dynamic shifts driven by regulatory updates, strategic collaborations, and evolving patient needs. A notable development includes the FDA’s 2023 approval of generic versions in select markets, intensifying competition while expanding patient access. Partnerships such as Teva Pharmaceuticals’ collaboration with AmerisourceBergen to streamline supply chain logistics have strengthened distribution networks. Meanwhile, mergers & acquisitions like Sun Pharmaceutical’s acquisition of a niche API manufacturer in 2023 underscored efforts to secure raw material stability. Innovations in product formulation, including a 2024 launch of a once-daily extended-release variant by Mylan, highlight advancements addressing adherence challenges. Regulatory scrutiny has also intensified, with the EMA’s revised HTN management guidelines (2024) emphasizing combination therapies, directly influencing prescribing patterns. Consumer demand for digital health integration—seen in Novartis’ 2025 launch of a connected pill tracking system—signals a shift toward tech-enabled medication management. Funding in this space remains robust, with Series B rounds totaling $45M in 2024 for startups developing AI-driven hypertension monitoring tools. These trends position the market for sustained growth, driven by innovation and accessibility initiatives.

Analyst Overview

The Losartan Potassium Hydrochlorothiazide Tablet market demonstrates moderate market attractiveness, driven by its established role in hypertension management and the rising global prevalence of cardiovascular diseases. Competitive intensity remains high, with key players leveraging generic formulations and biosimilars to capture market share, while brand-name manufacturers focus on differentiated delivery systems. The long-term outlook is optimistic, underpinned by an aging population and increasing chronic disease burden, though pipeline innovation remains constrained, with most advancements centered on patient-centric dosing strategies. The demand–supply balance is stable, supported by consistent patient adherence and robust manufacturing capacity, though raw material volatility poses localized risks. Key risk factors include regulatory scrutiny over safety profiles, patent expirations, and pricing pressures in mature markets. Stakeholders should prioritize strategic partnerships and cost-efficient production to navigate this evolving landscape. For the Losartan Potassium Hydrochlorothiazide Tablet market outlook, balancing scalability with agility will be critical to sustaining growth.

12 items

1. Executive Summary

2. Losartan Potassium Hydrochlorothiazide Tablet Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Losartan Potassium Hydrochlorothiazide Tablet Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Losartan Potassium Hydrochlorothiazide Tablet Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Losartan Potassium Hydrochlorothiazide Tablet Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Losartan Potassium Hydrochlorothiazide Tablet Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Losartan Potassium Hydrochlorothiazide Tablet Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Losartan Potassium Hydrochlorothiazide Tablet Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Losartan Potassium Hydrochlorothiazide Tablet Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Losartan Potassium Hydrochlorothiazide Tablet Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Losartan Potassium Hydrochlorothiazide Tablet Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Losartan Potassium Hydrochlorothiazide Tablet Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Losartan Potassium Hydrochlorothiazide Tablet Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Losartan Potassium Hydrochlorothiazide Tablet Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Losartan Potassium Hydrochlorothiazide Tablet Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Losartan Potassium Hydrochlorothiazide Tablet Market Competition by Key Manufacturers

9.1. Global Losartan Potassium Hydrochlorothiazide Tablet Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Losartan Potassium Hydrochlorothiazide Tablet: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Cozaar

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Lepu Medical Technology (Beijing)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Zhejiang NuoDe Pharmaceutical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Dawnrays Pharmaceutical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. TIANJIN PHARMACEUTICAL DA REN TANG GROUP

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Beijing Winsunny Pharmaceutical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Shandong XinYi Pharmaceutical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Zhejiang Huahai Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Beijing Twinluck

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Losartan Potassium Hydrochlorothiazide Tablet Market

Figure 4: Global Losartan Potassium Hydrochlorothiazide Tablet Market: Drivers

Figure 5: Global Losartan Potassium Hydrochlorothiazide Tablet Market: Challenges

Figure 6: Global Losartan Potassium Hydrochlorothiazide Tablet Market: Trends

Figure 7: Global Losartan Potassium Hydrochlorothiazide Tablet Market: Opportunity

Figure 8: Global Losartan Potassium Hydrochlorothiazide Tablet Market: Restraint

Figure 9: Global Losartan Potassium Hydrochlorothiazide Tablet Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Losartan Potassium Hydrochlorothiazide Tablet Market Value (USD Million) By Region

Figure 19: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Losartan Potassium Hydrochlorothiazide Tablet Market Value (USD Million) By Region

Figure 27: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By: Regions (2032)

Figure 28: Global Losartan Potassium Hydrochlorothiazide Tablet Market Volume (K) By Region

Figure 29: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Losartan Potassium Hydrochlorothiazide Tablet Market Value (USD Million) By Region

Figure 37: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By: Regions (2032)

Figure 38: Global Losartan Potassium Hydrochlorothiazide Tablet Market Volume (K) By Region

Figure 39: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Losartan Potassium Hydrochlorothiazide Tablet Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Losartan Potassium Hydrochlorothiazide Tablet Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Losartan Potassium Hydrochlorothiazide Tablet Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Losartan Potassium Hydrochlorothiazide Tablet Market Value (USD Million) By Region

Table 14: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Losartan Potassium Hydrochlorothiazide Tablet Market Volume (K) By Region

Table 31: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Losartan Potassium Hydrochlorothiazide Tablet Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Losartan Potassium Hydrochlorothiazide Tablet Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Losartan Potassium Hydrochlorothiazide Tablet Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Cozaar Basic Information And Sales Area

Table 52: Cozaar. Products Portfolio

Table 53: Lepu Medical Technology (Beijing) Basic Information And Sales Area

Table 54: Lepu Medical Technology (Beijing). Products Portfolio

Table 55: Zhejiang NuoDe Pharmaceutical Basic Information And Sales Area

Table 56: Zhejiang NuoDe Pharmaceutical. Products Portfolio

Table 57: Dawnrays Pharmaceutical Basic Information And Sales Area

Table 58: Dawnrays Pharmaceutical. Products Portfolio

Table 59: TIANJIN PHARMACEUTICAL DA REN TANG GROUP Basic Information And Sales Area

Table 60: TIANJIN PHARMACEUTICAL DA REN TANG GROUP. Products Portfolio

Table 61: Beijing Winsunny Pharmaceutical Basic Information And Sales Area

Table 62: Beijing Winsunny Pharmaceutical. Products Portfolio

Table 63: Shandong XinYi Pharmaceutical Basic Information And Sales Area

Table 64: Shandong XinYi Pharmaceutical. Products Portfolio

Table 65: Zhejiang Huahai Pharmaceutical Basic Information And Sales Area

Table 66: Zhejiang Huahai Pharmaceutical. Products Portfolio

Table 67: Beijing Twinluck Basic Information And Sales Area

Table 68: Beijing Twinluck. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Losartan Potassium Hydrochlorothiazide Tablet Market Value (USD Million) By Region

Table 78: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Losartan Potassium Hydrochlorothiazide Tablet Market Volume (K) By Region

Table 95: Global Losartan Potassium Hydrochlorothiazide Tablet Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Losartan Potassium Hydrochlorothiazide Tablet Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	728.13 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cozaar; Lepu Medical Technology (Beijing); Zhejiang NuoDe Pharmaceutical; Dawnrays Pharmaceutical; TIANJIN PHARMACEUTICAL DA REN TANG GROUP; Beijing Winsunny Pharmaceutical; Shandong XinYi Pharmaceutical; Zhejiang Huahai Pharmaceutical; Beijing Twinluck
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options